查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1457069

益生菌營養補充食品- 2024 年至 2029 年預測

Probiotics Dietary Supplements Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

益生菌營養補充食品預計將從2022年的64.82億美元成長到2029年的97.95億美元，複合年成長率為6.08%。

益生菌營養補充中發現的活有益細菌食品腸道菌叢的健康平衡，並支持免疫和消化器官系統活動。益生菌營養補充食品多種形式，包括膠囊、優格和發酵食品，經常服用來改善腸道健康。由於消費者對預防性保健的興趣日益濃厚，人們對腸道健康對整體健康影響的認知不斷提高，以及證明益生菌潛在益處的研究和開發不斷增加，益生菌越來越受歡迎。由於抗生素的使用、消化器官系統健康問題的普遍存在以及向機能性食品的轉變，益生菌營養補充的銷售量食品增加。

健康意識的提高正在推動益生菌營養補充食品的發展。

營養補充食品在很大程度上是由於人們對腸道健康和消化系統疾病的了解不斷增加而形成的。隨著人們越來越意識到健康的腸道菌叢與整體健康之間的複雜關係，對益生菌錠劑的需求正在增加。知識的成長不僅鼓勵了一系列專門針對消化器官系統健康的產品的創造和促銷，而且使人們能夠對自己的健康做出更好的決定。泰國等國家的旅遊業正在成長，許多遊客前往泰國旅遊。這導致旅行者腹瀉增加，這是從開發中國家到發展中國家的旅行者的常見健康問題。根據旅遊和體育部的資料，2022年訪問泰國的外國遊客人數為8,824,049人次。預計到 2023 年，這一數字將進一步增加至 24,838,066，對預測期內的益生菌營養補充食品產生正面影響。

此外，益生菌營養補充越來越食品越來越多的糖尿病患者的歡迎，這可能是因為它們有助於控制血糖值並促進代謝健康。因此，益生菌營養補充食品預計將成長並影響客戶的偏好。根據美國國家醫學圖書館的數據，預計到 2020 年，30 歲及以上的韓國人中將有 16.7% 患有糖尿病。 2019-2020年，65.8%的糖尿病患者了解自己的病情並正在接受降血糖藥物治療。糖尿病在韓國成年人中仍然非常流行。 2019-2020年，只有9.7%的糖尿病患者血糖、血壓、血脂得到完美控制。我們需要不斷評估該國的糖尿病資料，並發起全國性宣傳活動，以提高糖尿病意識並加強全面的糖尿病護理。

北美益生菌營養補充食品預計將穩定成長。

益生菌營養補充食品您的身體免受大腸激躁症、腹瀉和乳糖不耐受感染疾病等腸道問題的影響。美國發炎性腸道疾病疾病的盛行率不斷上升，預計將顯著推動食品國對益生菌營養補充的需求，並促進整體市場成長。根據美國胃腸病學會（AGA）統計，大約有6000萬至7000萬美國患有胃腸道疾病，到2021年，近40%的人口將因令人不快的腸道活動暫停而患上日常疾病。胃腸道疾病在老年人中發病率很高，且在美國呈現顯著成長趨勢。根據世界銀行預測，到2022年，17%的美國人口將超過65歲。而且，各種產品的推出以及在美國益生菌生產工廠的建立，正在進一步支持這些營養補充的市場成長。例如，2022年9月，皇家帝斯曼的「鼠李糖乳桿菌19070-2」和「羅伊氏乳桿菌12246-CU」益生菌菌株獲得FDA核准，使該公司能夠在美國市場提供腸道食品營養補充方案。同樣，2019 年 7 月，杜邦公司在紐約開設了一家最先進的發酵工廠，生產用於食品和飲料、飲料和營養補充的高品質益生菌。

目錄

第1章 簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 調查過程

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章益生菌營養補充食品：依菌株類型

  • 介紹
  • 乳酸菌
  • 雙歧桿菌
  • 其他

第6章益生菌營養補充食品：依健康細分市場

  • 介紹
  • 腸道健康
  • 整體健康
  • 免疫
  • 精神健康
  • 其他

第7章益生菌食品營養補充市場：依銷售管道分類

  • 介紹
  • 超級市場/大賣場
  • 藥局
  • 線上
  • 其他

第8章益生菌營養補充食品：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作

第10章 公司簡介

  • DuPont Inc.
  • Chr. Hansen Holding A/S
  • Probi（Symrise AG）
  • Lifeway Foods, Inc.
  • Kibow Biotech
  • Pharmavite LLC（Otsuka Pharmaceutical）
  • DSM
  • BioGaia
  • UniqueBiotech
  • Projoy Probiotic
簡介目錄
Product Code: KSI061611142

The probiotics dietary supplements market is expected to grow at a CAGR of 6.08% from US$6.482 billion in 2022 to US$9.795 billion by 2029.

Live beneficial bacteria included in probiotics dietary supplements help maintain a healthy balance of gut microflora, which supports immunological and digestive system activities. They may be obtained in a variety of forms, including capsules, yoghurts, and fermented meals, and are frequently taken to improve gut health. Probiotics dietary supplements are gaining popularity due to rising consumer interest in preventative healthcare, growing awareness of the influence of gut health on overall well-being, and increasing research and development demonstrating the potential advantages of probiotics. Probiotic supplement sales are also rising as a result of the growing prevalence of antibiotic use, digestive health problems, and a shift toward functional foods.

Increasing health awareness propels the probiotics dietary supplements market.

The dietary supplements market is being significantly shaped by the rise in knowledge of gut health and digestive disorders. Probiotic pills are in high demand as people become more aware of the complex relationship between a healthy gut microbiota and overall well-being. This increased knowledge not only encourages the creation and promotion of a wide range of goods aimed only at digestive health but also gives people the ability to make better decisions regarding their health. The growing tourism sector in countries like Thailand is leading to a large number of tourists visiting the country. This is leading to rising cases of traveler's diarrhea which is a common health problem among visitors from developed to developing countries. As per the data from the Ministry of Tourism and Sports in Thailand, the number of foreign tourists travelling to Thailand was 88,24,049 in 2022. This number further increased in 2023 to 2,48,38,066 which is anticipated to have a positive impact on the probiotics dietary supplements market during the forecast period.

Furthermore, probiotics dietary supplements are becoming more popular as diabetes rates rise, possibly because of their ability to help control blood sugar levels and enhance metabolic health. Owing to this, the market for probiotic supplements is anticipated to grow and influence customer preferences. As per the National Library of Medicine, in 2020, 16.7% of Korean people thirty years of age or older were predicted to have diabetes mellitus. 65.8% of people with diabetes mellitus from 2019 to 2020 were aware of their condition and received treatment with antidiabetic drugs. Among adult Koreans, diabetes mellitus remained highly prevalent. From 2019 to 2020, only 9.7% of persons with diabetes mellitus were able to maintain perfect glycemic, blood pressure, and lipid management. It is necessary to continuously assess the country's diabetes data and launch a nationwide campaign to raise awareness of diabetes mellitus and enhance all-encompassing diabetes treatment.

It is projected that the probiotics dietary supplements market in the North American region will grow steadily.

Probiotics dietary supplements prevent a body from bowel problems such as irritable bowel syndrome, diarrhoea, and lactose intolerance infections among others. The growing prevalence of inflammatory bowel disease in the United States is anticipated to majorly drive the demand for probiotics dietary supplements in the country, thereby augmenting the overall market growth. According to the American Gastroenterological Association (AGA), about 60-70 million Americans are suffering from gastrointestinal diseases, and in 2021, nearly 40% of the population stopped routine activities due to uncomfortable bowel symptoms. Digestive diseases have a high prevalence rate in older people, which is also witnessing significant growth in the US. According to the World Bank, in 2022, 17% of the US population aged 65 years and above. Additionally, various product launches and establishments of probiotics production plants in the United States have further propelled the market growth for such supplements. For instance, in September 2022, Royal DSM's "Lactobacillus rhamnosus 19070-2" and "Lactobacillus reuteri 12246-CU" probiotics strain were approved by the FDA which enabled the company to strengthen its gut health solutions offerings in the US market and explore more innovations in dietary supplement category. Likewise, in July 2019, DuPont opened its state-of-the-art fermentation plant in New York to produce high-quality probiotics for food & beverage and dietary supplements.

Market Key Developments

  • March 2023: Roquette a world leader in plant-based ingredients and a top supplier of pharmaceutical and nutraceutical excipients invited the health and nutrition industry to explore a more flexible, reliable, and consumer-focused future for probiotic supplements, introduced the PEARLITOL(R) ProTec. This solution is a novel plant-based co-processed combination of mannitol and maize starch, that stabilizes and extends the shelf life of active substances that are sensitive to moisture, such as probiotics. It also opens up new possibilities for consumer-friendly dose formulations.

Segmentation:

By Strain Type:

  • Lactobacillus
  • Bifidobacterium
  • Others

By Health Area:

  • Gut Health
  • General Health
  • Immunity
  • Mental Well-Being
  • Others

By Sales Channel:

  • Supermarket/Hypermarket
  • Pharmacy
  • Online
  • Others

By Geography

  • North America

By Strain Type

By Health Area

By Sales Channel

By Country

  • United States
  • Canada
  • Mexico
  • South America

By Strain Type

By Health Area

By Sales Channel

By Country

  • Brazil
  • Argentina
  • Others
  • Europe

By Strain Type

By Health Area

By Sales Channel

By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa

By Strain Type

By Health Area

By Sales Channel

By Country

  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific

By Strain Type

By Health Area

By Sales Channel

By Country

  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Australia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY STRAIN TYPE

  • 5.1. Introduction
  • 5.2. Lactobacillus
  • 5.3. Bifidobacterium
  • 5.4. Others

6. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY HEALTH AREA

  • 6.1. Introduction
  • 6.2. Gut Health
  • 6.3. General Health
  • 6.4. Immunity
  • 6.5. Mental Well-Being
  • 6.6. Others

7. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY SALES CHANNEL

  • 7.1. Introduction
  • 7.2. Supermarket/Hypermarket
  • 7.3. Pharmacy
  • 7.4. Online
  • 7.5. Others

8. PROBIOTICS DIETARY SUPPLEMENTS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Strain Type
    • 8.2.2. By Health Area
    • 8.2.3. By Sales Channel
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Strain Type
    • 8.3.2. By Health Area
    • 8.3.3. By Sales Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Strain Type
    • 8.4.2. By Health Area
    • 8.4.3. By Sales Channel
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Strain Type
    • 8.5.2. By Health Area
    • 8.5.3. By Sales Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Strain Type
    • 8.6.2. By Health Area
    • 8.6.3. By Sales Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Australia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

  • 10.1. DuPont Inc.
  • 10.2. Chr. Hansen Holding A/S
  • 10.3. Probi (Symrise AG)
  • 10.4. Lifeway Foods, Inc.
  • 10.5. Kibow Biotech
  • 10.6. Pharmavite LLC (Otsuka Pharmaceutical)
  • 10.7. DSM
  • 10.8. BioGaia
  • 10.9. UniqueBiotech
  • 10.10. Projoy Probiotic